R R

What Is Qamzova?

Qamzova is a prescription injectable medication containing meloxicam, a nonsteroidal anti-inflammatory drug (NSAID). It is approved for the management of moderate to severe pain in adults, either alone or with non-NSAID pain medications. Qamzova is administered intravenously by healthcare professionals and is not an oral tablet. Its pain-relieving effects may take several hours to become meaningful, so it is not recommended as the sole medication when rapid pain relief is required. It carries boxed warnings for serious cardiovascular and gastrointestinal complications associated with NSAIDs.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Qamzova?

Qamzova is a prescription injectable medication containing meloxicam, a nonsteroidal anti-inflammatory drug (NSAID). It is approved for the management of moderate to severe pain in adults, either alone or with non-NSAID pain medications. Qamzova is administered intravenously by healthcare professionals and is not an oral tablet. Its pain-relieving effects may take several hours to become meaningful, so it is not recommended as the sole medication when rapid pain relief is required. It carries boxed warnings for serious cardiovascular and gastrointestinal complications associated with NSAIDs.

read more about qamzova ...

Copy this HTML:

Copy HTML Copied!

How Does Qamzova Work?

Qamzova contains meloxicam, which inhibits cyclooxygenase enzymes involved in producing prostaglandins. Prostaglandins contribute to inflammation, pain signaling, and other physiological functions. Reducing their production helps decrease pain and inflammatory activity. Meloxicam also affects prostaglandins involved in maintaining blood flow to the kidneys and protecting the digestive lining, contributing to some of its serious adverse effects. Qamzova works differently from opioid pain relievers and does not act through opioid receptors. Its onset of meaningful pain relief can be delayed after administration.

What Type of Pain Does Qamzova Treat?

Qamzova is approved for moderate to severe pain in adults and can be used alone or combined with non-NSAID analgesics. It may be administered in clinical settings where intravenous pain management is appropriate. Because meaningful pain relief can take two to three hours in studied settings, clinicians may use a faster-acting non-NSAID pain reliever when immediate relief is necessary. Qamzova is not intended for pediatric patients. Treatment selection considers kidney function, cardiovascular risk, gastrointestinal bleeding history, and previous reactions to aspirin or other NSAIDs.

How Is Qamzova Administered?

The recommended Qamzova dose is 30 mg intravenously once daily, administered as a bolus injection over approximately 15 seconds. It is supplied as a single-dose vial containing 30 mg of meloxicam per milliliter. Healthcare professionals administer the medication and monitor the patient's pain response. Patients should be adequately hydrated before treatment to reduce kidney-related risks. Qamzova should be used for the shortest duration consistent with the patient's treatment needs. If additional pain relief is required, clinicians may use an appropriate short-acting non-NSAID analgesic rather than increasing the prescribed Qamzova dose.

What Are the Side Effects and Warnings of Qamzova?

Qamzova can cause nausea, gastrointestinal discomfort, constipation, and other NSAID-related adverse effects. It carries boxed warnings for serious cardiovascular thrombotic events, including heart attack and stroke, and gastrointestinal bleeding, ulceration, or perforation, which can be fatal. Other risks include kidney injury, liver toxicity, allergic reactions, severe skin reactions, and fluid retention. Qamzova is contraindicated during coronary artery bypass graft surgery and in patients with certain NSAID-related allergic reactions. NSAID use from approximately 20 weeks of pregnancy can cause fetal kidney complications, with additional risks later in pregnancy. Chest pain, black stools, severe abdominal pain, or breathing difficulties requires urgent medical attention.

Common Questions About Qamzova

Is Qamzova the same as meloxicam?

Yes. Qamzova contains meloxicam in a prescription intravenous formulation. Oral meloxicam products have different doses and approved indications.

Is Qamzova an opioid medication?

No. Qamzova is a nonsteroidal anti-inflammatory drug that reduces prostaglandin production. It does not contain an opioid.

How often is Qamzova administered?

Qamzova is administered intravenously at a recommended dose of 30 mg once daily by healthcare professionals.

Does Qamzova provide immediate pain relief?

Not necessarily. Meaningful pain relief can take several hours, so Qamzova alone is not recommended when rapid-onset analgesia is required.

References

DailyMed - QAMZOVA (meloxicam) injection. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=385fd779-1be1-49ae-8213-750b96ecc997. Date Accessed November 2, 2026.

Meloxicam. LiverTox. https://www.ncbi.nlm.nih.gov/books/NBK548278/. Date Accessed November 2, 2026.

Meloxicam. MedlinePlus. https://medlineplus.gov/druginfo/meds/a601242.html. Date Accessed November 2, 2026.

Meloxicam. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/meloxicam. Date Accessed November 2, 2026.

QAMZOVA (Meloxicam Injection) Prescribing Information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=385fd779-1be1-49ae-8213-750b96ecc997. Date Accessed November 2, 2026.